2017
DOI: 10.1002/pd.5108
|View full text |Cite
|
Sign up to set email alerts
|

Gonadal mosaicism and non‐invasive prenatal diagnosis for ‘reassurance’ in sporadic paternal age effect (PAE) disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 25 publications
(35 reference statements)
0
14
0
Order By: Relevance
“…ATAD3, A Hotspot for Genomic Variation and Pathogenic CNVs Pediatric mitochondrial disease, including lethal perinatal presentations, is most often thought to have autosomal recessive inheritance. 1 The de novo nature of ATAD3 duplications markedly alters the reproductive landscape for families, with the recurrence risk estimated to be 1%-4% for gonadal mosaicism, 46 rather than 25%. The identification of these recurrent pathogenic duplications and other ATAD3 variants is also shifting the genomic landscape of mitochondrial diagnostics.…”
Section: Discussionmentioning
confidence: 99%
“…ATAD3, A Hotspot for Genomic Variation and Pathogenic CNVs Pediatric mitochondrial disease, including lethal perinatal presentations, is most often thought to have autosomal recessive inheritance. 1 The de novo nature of ATAD3 duplications markedly alters the reproductive landscape for families, with the recurrence risk estimated to be 1%-4% for gonadal mosaicism, 46 rather than 25%. The identification of these recurrent pathogenic duplications and other ATAD3 variants is also shifting the genomic landscape of mitochondrial diagnostics.…”
Section: Discussionmentioning
confidence: 99%
“…Direct methods to identify the source of the originating mutations within individual seminiferous tubules of testes (removed because of incidental pathology) were recently described [55, 56], providing further support for the proposed pathophysiological mechanism. The clinical significance of this knowledge is that sibling recurrence risk for de novo FGFR2 and FGFR3 mutations is likely to be exceptionally low, making it justified to reassure parents and mitigate demand for prenatal diagnosis [57]. …”
Section: Genetic Counselling In Craniosynsotosismentioning
confidence: 99%
“…90 The unprecedented commercial drive to implement NIPT for aneuploidy over the past decade has meant that we have learnt a lot about cell-free fetal DNA. It has clearly changed the face of prenatal diagnosis and no doubt will continue to pose ethical challenges 93 as our understanding improves and its potential scope broadens. We must hope that the high standards of validation that are required in public sector laboratories can be applied to the commercial sector, which has been key in driving progress, and that we can hasten slowly and with care to avoid harm as new tests are developed.…”
Section: A Decade Of Cell-free Dna Testingmentioning
confidence: 99%